United Therapeutics' GAAP net income for 3 months of 2022 was $239.9 million, up 8.5 times from $28.3 million in the previous year. Revenue increased by 19.2% to $451.9 million compared to $379.1 million a year earlier.
United Therapeutics' GAAP net income for 3 months of 2022 was $239.9 million, up 8.5 times from $28.3 million in the previous year. Revenue increased by 19.2% to $451.9 million compared to $379.1 million a year earlier. 
ir.unither.com
English (US) 